Eikonoklastes Therapeutics
PrivateLast Round
VC Round
Jul 29, 2025
Total Funding Raised
$2.8M
Company Overview
Eikonoklastes Therapeutics is a biotechnology company developing novel gene therapies and immunotherapies for neurodegenerative diseases and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eikonoklastes Therapeutics Comparables
Compare Eikonoklastes Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VectorY Therapeutics | 81% | |
| SineuGene Therapeutics | 79% | |
| Latus Bio | 78% |
Eikonoklastes Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 29, 2025 | ||||
| VC Round | Jun 12, 2024 | ||||
| Series A | Jun 28, 2021 | ||||
| Seed | Jul 22, 2020 |
Key People
Founding team and executive leadership
Eikonoklastes Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CincyTech | Series A, Seed |
| Rev1 Ventures | Series A |
| JobsOhio Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors grew 846% MoM, from 136 to 1.3K.
- Feb 2, 2026
Monthly visitors grew 5475% MoM, from 24 to 1.3K.
Eikonoklastes Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Eikonoklastes Therapeutics's valuation, stock price, and market status.
Is Eikonoklastes Therapeutics a public or private company?
Eikonoklastes Therapeutics is a private company.
What is the current stock price of Eikonoklastes Therapeutics?
Eikonoklastes Therapeutics is a private company, so its shares have no public market price. Caplight tracks Eikonoklastes Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eikonoklastes Therapeutics worth (valuation)?
Valuation information for Eikonoklastes Therapeutics is not publicly available.
Can I buy Eikonoklastes Therapeutics stock?
Eikonoklastes Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eikonoklastes Therapeutics's last funding round?
Eikonoklastes Therapeutics's most recent funding round was VC Round on July 29, 2025.
Who are the main investors in Eikonoklastes Therapeutics?
Key investors in Eikonoklastes Therapeutics include CincyTech.
Will Eikonoklastes Therapeutics IPO soon?
No public IPO plans have been announced for Eikonoklastes Therapeutics.
How can I track Eikonoklastes Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Eikonoklastes Therapeutics's shares on secondary markets.